Pankti Reid MD MPH
Myositis, Rheumatoid Arthritis & Related, Vasculitis, Clinical Pharmacology
Assistant Professor
Join to View Full Profile
5758 South Maryland AvenueChicago, IL 60637
Phone+1 773-702-6119
Dr. Reid is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Pankti Reid specializes in rheumatology. She cares for patients with an array of rheumatic diseases such as rheumatoid arthritis, systemic lupus erythematous, vasculitis, myositis, etc. In particular, she has a dedicated clinic for evaluation and management of patients with immune-related adverse events (irAEs), which are side effects to cancer immunotherapy agents like checkpoint inhibitors.
Education & Training
University of ChicagoFellowship, Rheumatology, 2018
University of Cincinnati Medical Center/College of MedicineResidency, Internal Medicine, 2013 - 2016
Ohio State University College of MedicineClass of 2013
Certifications & Licensure
IL State Medical License 2016 - 2026
OH State Medical License 2013 - 2017
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Rheumatology
Clinical Trials
- Low-dose Tocilizumab Versus Standard of Care in Hospitalized Patients With COVID-19 Start of enrollment: 2020 Sep 10
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Comparative safety of biologic and targeted synthetic disease-modifying anti-rheumatic drugs for cardiovascular outcomes in rheumatoid arthritis.Xavier Sendaydiego, Laura S Gold, Maureen Dubreuil, James S Andrews, Pankti Reid
Rheumatology. 2025-02-12 - Use of Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drugs and Cancer Risk.Xavier Sendaydiego, Laura S Gold, Maureen Dubreuil, James S Andrews, Pankti Reid
JAMA Network Open. 2024-11-04 - 3 citationsNCCN Guidelines® Insights: Management of Immunotherapy-Related Toxicities, Version 2.2024.John A Thompson, Bryan J Schneider, Julie Brahmer, Mohammad Abu Zaid, Amaka Achufusi
Journal of the National Comprehensive Cancer Network. 2024-11-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
